Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression

Weiping Su, Mihaela Sin, Andrea Darrow, Lawrence (Larry) Sherman

    Research output: Contribution to journalArticle

    20 Citations (Scopus)

    Abstract

    Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive malignancies that arise within peripheral nerves. These tumors occur with increased incidence in patients with neurofibromatosis type 1 (NF1), exhibiting increased Ras activity due to loss of the NF1 gene product, neurofibromin, and abnormal expression of the epidermal growth factor receptor (EGFR). We previously found that MPNSTs express increased levels of the CD44 family of transmembrane glycoproteins that have been implicated in tumor cell invasion and metastasis. In two MPNST cell lines, we have found that elevated CD44 expression and cell invasion are dependent on Src kinase activity but are independent of mitogen-activated protein kinases (MAPK) kinase (MEK) activity. In contrast, inhibition of Src kinase activity has no influence on MPNST cell proliferation. Reduction of CD44 levels, using antisense oligonucleotides, results in reduced MPNST cell invasion in vitro, suggesting that Src contributes in part to MPNST cell invasion by increasing CD44 levels. At least some of this increased CD44 expression results from elevated EGFR levels through a Src-dependent mechanism, consistent with the notion that EGFR promotes constitutive Src activation in MPNSTs. These data indicate that Src and CD44 are putative targets for the treatment of MPNST invasion and metastasis.

    Original languageEnglish (US)
    Pages (from-to)350-358
    Number of pages9
    JournalGLIA
    Volume42
    Issue number4
    DOIs
    StatePublished - Jun 1 2003

    Fingerprint

    Neurilemmoma
    Neurofibromin 1
    Epidermal Growth Factor Receptor
    src-Family Kinases
    Mitogen-Activated Protein Kinase Kinases
    Neoplasm Metastasis
    Neoplasms
    Neurofibromatosis 1
    Antisense Oligonucleotides
    Tumor Cell Line
    Peripheral Nerves
    Glycoproteins
    Cell Proliferation
    Incidence

    Keywords

    • CD44
    • Malignant peripheral nerve sheath tumor
    • Neurofibromatosis
    • Ras
    • Src

    ASJC Scopus subject areas

    • Immunology

    Cite this

    Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression. / Su, Weiping; Sin, Mihaela; Darrow, Andrea; Sherman, Lawrence (Larry).

    In: GLIA, Vol. 42, No. 4, 01.06.2003, p. 350-358.

    Research output: Contribution to journalArticle

    @article{e9d9973d82ac4378b746e8cdfa1b7b33,
    title = "Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression",
    abstract = "Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive malignancies that arise within peripheral nerves. These tumors occur with increased incidence in patients with neurofibromatosis type 1 (NF1), exhibiting increased Ras activity due to loss of the NF1 gene product, neurofibromin, and abnormal expression of the epidermal growth factor receptor (EGFR). We previously found that MPNSTs express increased levels of the CD44 family of transmembrane glycoproteins that have been implicated in tumor cell invasion and metastasis. In two MPNST cell lines, we have found that elevated CD44 expression and cell invasion are dependent on Src kinase activity but are independent of mitogen-activated protein kinases (MAPK) kinase (MEK) activity. In contrast, inhibition of Src kinase activity has no influence on MPNST cell proliferation. Reduction of CD44 levels, using antisense oligonucleotides, results in reduced MPNST cell invasion in vitro, suggesting that Src contributes in part to MPNST cell invasion by increasing CD44 levels. At least some of this increased CD44 expression results from elevated EGFR levels through a Src-dependent mechanism, consistent with the notion that EGFR promotes constitutive Src activation in MPNSTs. These data indicate that Src and CD44 are putative targets for the treatment of MPNST invasion and metastasis.",
    keywords = "CD44, Malignant peripheral nerve sheath tumor, Neurofibromatosis, Ras, Src",
    author = "Weiping Su and Mihaela Sin and Andrea Darrow and Sherman, {Lawrence (Larry)}",
    year = "2003",
    month = "6",
    day = "1",
    doi = "10.1002/glia.10206",
    language = "English (US)",
    volume = "42",
    pages = "350--358",
    journal = "GLIA",
    issn = "0894-1491",
    publisher = "John Wiley and Sons Inc.",
    number = "4",

    }

    TY - JOUR

    T1 - Malignant peripheral nerve sheath tumor cell invasion is facilitated by Src and aberrant CD44 expression

    AU - Su, Weiping

    AU - Sin, Mihaela

    AU - Darrow, Andrea

    AU - Sherman, Lawrence (Larry)

    PY - 2003/6/1

    Y1 - 2003/6/1

    N2 - Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive malignancies that arise within peripheral nerves. These tumors occur with increased incidence in patients with neurofibromatosis type 1 (NF1), exhibiting increased Ras activity due to loss of the NF1 gene product, neurofibromin, and abnormal expression of the epidermal growth factor receptor (EGFR). We previously found that MPNSTs express increased levels of the CD44 family of transmembrane glycoproteins that have been implicated in tumor cell invasion and metastasis. In two MPNST cell lines, we have found that elevated CD44 expression and cell invasion are dependent on Src kinase activity but are independent of mitogen-activated protein kinases (MAPK) kinase (MEK) activity. In contrast, inhibition of Src kinase activity has no influence on MPNST cell proliferation. Reduction of CD44 levels, using antisense oligonucleotides, results in reduced MPNST cell invasion in vitro, suggesting that Src contributes in part to MPNST cell invasion by increasing CD44 levels. At least some of this increased CD44 expression results from elevated EGFR levels through a Src-dependent mechanism, consistent with the notion that EGFR promotes constitutive Src activation in MPNSTs. These data indicate that Src and CD44 are putative targets for the treatment of MPNST invasion and metastasis.

    AB - Malignant peripheral nerve sheath tumors (MPNSTs) are aggressive malignancies that arise within peripheral nerves. These tumors occur with increased incidence in patients with neurofibromatosis type 1 (NF1), exhibiting increased Ras activity due to loss of the NF1 gene product, neurofibromin, and abnormal expression of the epidermal growth factor receptor (EGFR). We previously found that MPNSTs express increased levels of the CD44 family of transmembrane glycoproteins that have been implicated in tumor cell invasion and metastasis. In two MPNST cell lines, we have found that elevated CD44 expression and cell invasion are dependent on Src kinase activity but are independent of mitogen-activated protein kinases (MAPK) kinase (MEK) activity. In contrast, inhibition of Src kinase activity has no influence on MPNST cell proliferation. Reduction of CD44 levels, using antisense oligonucleotides, results in reduced MPNST cell invasion in vitro, suggesting that Src contributes in part to MPNST cell invasion by increasing CD44 levels. At least some of this increased CD44 expression results from elevated EGFR levels through a Src-dependent mechanism, consistent with the notion that EGFR promotes constitutive Src activation in MPNSTs. These data indicate that Src and CD44 are putative targets for the treatment of MPNST invasion and metastasis.

    KW - CD44

    KW - Malignant peripheral nerve sheath tumor

    KW - Neurofibromatosis

    KW - Ras

    KW - Src

    UR - http://www.scopus.com/inward/record.url?scp=0037782147&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0037782147&partnerID=8YFLogxK

    U2 - 10.1002/glia.10206

    DO - 10.1002/glia.10206

    M3 - Article

    C2 - 12730955

    AN - SCOPUS:0037782147

    VL - 42

    SP - 350

    EP - 358

    JO - GLIA

    JF - GLIA

    SN - 0894-1491

    IS - 4

    ER -